2017

1. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

   Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

2. Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

   Journal of Hepatology, Vol. 66, Núm. 6, pp. 1138-1148

3. Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System

   Medicina Clinica, Vol. 148, Núm. 6, pp. 277-282